EU-India Free Trade Agreement: Investment and Intellectual Property Chapters Threaten Access to Medicines
The draft Free Trade Agreement (FTA) endangers access to medicines for poor people – in India and around the world.
A briefing document from MSF, ITPC, APN+, Health Poverty Action, Oxfam and HAI on how the investment chapter in the pending EU-India Free Trade Agreement sets forth new “TRIPS-plus-plus” rules that will limit government action to promote public health and, in particular, access to affordable medicines.
Downloads
Summary version of "EU-India Free Trade Agreement: Investment and Intellectual Property Chapters Threaten Access to Medicines" (2 pages)